Literature DB >> 28844940

Subclonal Evolution of Cancer-Related Gene Mutations in p53 Immunopositive Patches in Human Skin.

Amel A Albibas1, Matthew J J Rose-Zerilli2, Chester Lai3, Reuben J Pengelly4, Gabrielle A Lockett5, Jeffrey Theaker6, Sarah Ennis4, John W Holloway5, Eugene Healy7.   

Abstract

Normal sun-exposed skin contains numerous epidermal patches that stain positive for p53 protein (p53 immunopositive patches, PIPs), which are considered potential early precursors of skin cancer. Although the TP53 gene is mutated in many PIPs, it is unclear whether PIPs contain any other cancer-related mutations. Here we report that PIPs, predominantly <3,000 p53 immunopositive cells in size, within normal chronically exposed skin contain mutations in multiple genes that are mutated in cutaneous squamous cell cancers. These mutations in the PIPs were not detected within the non-PIP epidermis of corresponding normal chronically exposed skin. Although some of these genetic alterations are clonal in the PIPs, many of the mutations are subclonal within these lesions. Similar mutations are seen in later precancers (actinic keratoses and Bowen's disease). Our results demonstrate that PIPs in chronically exposed skin contain multiple mutations in cancer-related genes. In addition, the results indicate that the clonal evolution of mutations that are seen within later precancerous lesions and in established malignancy can also occur in PIPs within normal human skin.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28844940     DOI: 10.1016/j.jid.2017.07.844

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Emergence and Evolution of Mutational Hotspots in Sun-Damaged Skin.

Authors:  Jeffrey B Cheng; Raymond J Cho
Journal:  J Invest Dermatol       Date:  2018-01       Impact factor: 8.551

2.  p53 protein expression affected by TP53 polymorphism is associated with the biological behavior and prognosis of low rectal cancer.

Authors:  Guangzhe Zhang; Qian Xu; Zeyang Wang; Liping Sun; Zhi Lv; Jingwei Liu; Chengzhong Xing; Yuan Yuan
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

Review 3.  Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Authors:  Angelo Giuseppe Condorelli; Elena Dellambra; Elena Logli; Giovanna Zambruno; Daniele Castiglia
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

Review 4.  Mutant p53 in cell-cell interactions.

Authors:  Steven Pilley; Tristan A Rodriguez; Karen H Vousden
Journal:  Genes Dev       Date:  2021-04-01       Impact factor: 11.361

5.  Adverse Effects of Vemurafenib on Skin Integrity: Hyperkeratosis and Skin Cancer Initiation Due to Altered MEK/ERK-Signaling and MMP Activity.

Authors:  Marius Tham; Hans-Jürgen Stark; Anna Jauch; Catherine Harwood; Elizabeth Pavez Lorie; Petra Boukamp
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

Review 6.  Pathogenesis of Skin Carcinomas and a Stem Cell as Focal Origin.

Authors:  Frank R de Gruijl; Cornelis P Tensen
Journal:  Front Med (Lausanne)       Date:  2018-05-29

7.  Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells.

Authors:  Qing-Ling Zhang; Xue Mei Li; De-De Lian; Ming Ji Zhu; Su-Hyuk Yim; Jeung-Hoon Lee; Ri-Hua Jiang; Chang-Deok Kim
Journal:  Biomed Res Int       Date:  2019-11-22       Impact factor: 3.411

8.  CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.

Authors:  Chester Lai; George Coltart; Andrew Shapanis; Conor Healy; Ahmad Alabdulkareem; Sara Selvendran; Jeffrey Theaker; Matthew Sommerlad; Matthew Rose-Zerilli; Aymen Al-Shamkhani; Eugene Healy
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.